z-logo
open-access-imgOpen Access
Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis
Author(s) -
Mark W. Tenforde,
Margaret Mokomane,
Tshepo Leeme,
Raju K K Patel,
Nametso Lekwape,
Chandapiwa Ramodimoosi,
Bonno Dube,
Elizabeth A. Williams,
Kelebeletse O. Mokobela,
Ephraim Tawanana,
Tlhagiso Pilatwe,
William James Hurt,
Hannah K Mitchell,
Doreen L Banda,
Hunter H. Stone,
Mooketsi Molefi,
Kabelo Mokgacha,
Heston Phillips,
Paul C. Mullan,
Andrew P. Steenhoff,
Yohana Mashalla,
Madisa Mine,
Joseph N Jarvis
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix430
Subject(s) - medicine , incidence (geometry) , population , referral , meningitis , pediatrics , antiretroviral therapy , confidence interval , cryptococcosis , disease burden , demography , human immunodeficiency virus (hiv) , immunology , environmental health , viral load , family medicine , physics , sociology , optics
Botswana has a well-developed antiretroviral therapy (ART) program that serves as a regional model. With wide ART availability, the burden of advanced human immunodeficiency virus (HIV) and associated opportunistic infections would be expected to decline. We performed a nationwide surveillance study to determine the national incidence of cryptococcal meningitis (CM), and describe characteristics of cases during 2000-2014 and temporal trends at 2 national referral hospitals.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom